Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Aguado, Ana Belén
DOB: 18-APR-1982 (Age: 43)
Gender: female
ID: 2161-886928-9 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 23-DEC-2024

Problem list

Condition Onset Date Status
Prediabetes 20-Feb-2012 active
Anemia 20-Feb-2012 active

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 23-Dec-2024
Hepatitis A virus antigen only vaccine product 19-Dec-2022
Clostridium tetani toxoid antigen adsorbed only vaccine product 19-Dec-2022
SARS-CoV-2 mRNA vaccine 14-Jun-2021

Procedure History list

Procedure Date Reason
Radiography of humerus 06-Sep-2019 -
Bone immobilization 06-Sep-2019 Fracture of forearm
Suture open wound 16-Aug-2018 Laceration of thigh
Postoperative care 13-May-2016 History of tubal ligation (situation)
Ligation of bilateral fallopian tubes 13-May-2016 Sterilization requested (situation)
Parturition 07-Mar-2016 Normal pregnancy
Augmentation of labor 07-Mar-2016 Normal pregnancy

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
Mold 1981-06-29 active environment Allergic skin rash<br> </br>Sneezing
Allergy to substance 1981-06-29 active environment
Shellfish 1981-06-29 active food Anaphylaxis (disorder)<br> </br>Eruption of skin (disorder)

Care Plan

Active Planned Care / Goals Start Date Reason
Diabetes self management plan 20-Feb-2012 Prediabetes
  • Patient will implement lifestyle changes (diet, exercise, weight management) to lower risk of developing type 2 diabetes.
Self-care interventions 13-Jun-1981 -

Vital Signs

Vital Signs 2024-12-23 2022-12-19
Body Height 170.3 cm 170.3 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} 3 {score}
Body Weight 79.5 kg 79.5 kg
Body mass index (BMI) [Ratio] 27.4 kg/m2 27.4 kg/m2
Diastolic Blood Pressure 82 mm[Hg] 86 mm[Hg]
Systolic Blood Pressure 110 mm[Hg] 106 mm[Hg]
Heart rate 100 /min 97 /min
Respiratory rate 15 /min 14 /min

Pregnancy History

$
[#] Births total 1

Relevant diagnostic tests/laboratory data

Recent Lab Observations 23-DEC-2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 90.1 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.1 7 - 43 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 10.0 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 140.1 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 105.6 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.2 22 - 29 mmol/L

Device Use

Device Date (since)
Blood glucose meter (physical object) 20-Feb-2012